Global Next Generation Sequencing (NGS) Product Market Insights, Forecast to 2028

Genomics is science that studies the composition of biological genomes, the precise structure, interrelationships, and expression regulation of genes in a genome. In genomics, scientists analyze the genomic information of biological samples (tissue, cells, blood samples, etc.) using a novel gene sequencer.

Generation sequencing technology has been developed for 40 years. According to different sequencing principles, gene sequencing technology has been divided into three generations: the first generation of gene sequencing Sanger Sequencing, the second generation of gene sequencing NGS (Next Generation Sequencing), the third generation of gene sequencing TGS.

Next Generation Sequencing (NGS) is a high-throughput method for rapid sequencing of base pairs of DNA or RNA samples. Next generation sequencing systems can be divided by three parts, instruments, consumables and related services. At the same time, NGS also supports a wide range of applications, including gene expression profiling, chromosome counting, epigenetic change detection, and molecular analysis, which can drive discovery research and realize the bright future of personalized medicine.
Market Analysis and Insights: Global Next Generation Sequencing (NGS) Product Market
The global Next Generation Sequencing (NGS) Product market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Consumables and Reagents accounting for % of the Next Generation Sequencing (NGS) Product global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Life Science segment is altered to an % CAGR throughout this forecast period.
China Next Generation Sequencing (NGS) Product market size is valued at US$ million in 2021, while the North America and Europe Next Generation Sequencing (NGS) Product are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Next Generation Sequencing (NGS) Product landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Next Generation Sequencing (NGS) Product market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Next Generation Sequencing (NGS) Product market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Next Generation Sequencing (NGS) Product market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Next Generation Sequencing (NGS) Product market.
Global Next Generation Sequencing (NGS) Product Scope and Market Size
Next Generation Sequencing (NGS) Product market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Next Generation Sequencing (NGS) Product market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Consumables and Reagents
Instruments
Others
Segment by Application
Life Science
Traslational Medicine & Pharma
Others
By Company
Illumina
Thermo Fisher Scientific
BGI
LabCorp
Roche
PerkinElmer
Eurofins Scientific
New England Biolabs
Mgi Tech
Agilent Technologies
Promega
Natera
Norgen Biotek
LifeCodexx
Amoy Diagnostics
BioCat GmbH
Rightongene Biotechnology
Kindstar Global
CoWin Biotech
Berrygenomics
Capitalbio
QIAGEN
Annaroad Gene Technology
Find Biotechnology
Daan Gene
Novogene
Omixon
Swift Biosciences
NimaGen
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA